Tsutomu Fujito Selected Research

poliovirus receptor

6/2007	Necl-5/poliovirus receptor interacts in cis with integrin alphaVbeta3 and regulates its clustering and focal complex formation.
1/2007	Involvement of up-regulated Necl-5/Tage4/PVR/CD155 in the loss of contact inhibition in transformed NIH3T3 cells.
10/2005	Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3.
8/2004	Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Fujito Research Topics

Disease

4	Neoplasms (Cancer) 06/2007 - 11/2002
2	Neoplasm Metastasis (Metastasis) 02/2003 - 11/2002
1	Carcinoma (Carcinomatosis) 08/2004
1	Hepatocellular Carcinoma (Hepatoma) 07/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2003
1	Breast Neoplasms (Breast Cancer) 11/2002

Drug/Important Bio-Agent (IBA)

4	poliovirus receptorIBA 06/2007 - 08/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2007 - 10/2005
1	Integrin alphaVbeta3IBA 06/2007
1	Immunoglobulins (Immunoglobulin)IBA 10/2005
1	beta CateninIBA 07/2004
1	Monoclonal AntibodiesIBA 07/2004
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	titanium silicide (TS-1)IBA 02/2003
1	Cisplatin (Platino)FDA LinkGeneric 02/2003
1	Tumor Biomarkers (Tumor Markers)IBA 11/2002

Therapy/Procedure

1	Combination Drug Therapy (Combination Chemotherapy) 02/2003
1	Mastectomy (Mammectomy) 11/2002
1	Drug Therapy (Chemotherapy) 11/2002
1	Therapeutics 11/2002